Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Berg

Showing results (561-570 of 668) with videos related to

Pageof 67
Sort By:
Pediatric Blood & Cancer|September 25, 2012
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium studySusan M Blaney, Michael Tagen, Arzu Onar-Thomas, et al.
Advances in Health Sciences Education : Theory and Practice|September 1, 2011
Students' learning as the focus for shared involvement between universities and clinical practice: a didactic model for postgraduate degree projectsJ Öhlén, L Berg, E Björk Brämberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Brain : a Journal of Neurology|December 20, 2021
Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brainYouJin Lee, Morgan R Miller, Marty A Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Cancer|November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)James I Geller, Elizabeth Fox, Brian K Turpin, et al.
Cell|September 17, 2004
Identification of a human heme exporter that is essential for erythropoiesisJohn G Quigley, Zhantao Yang, Mark T Worthington, et al.
The Gerontologist|October 4, 2005
Driving and dementia of the Alzheimer type: beliefs and cessation strategies among stakeholdersMargaret A Perkinson, Marla L Berg-Weger, David B Carr, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2004
An integrative biology approach for analysis of drug action in models of human vascular inflammationEric J Kunkel, Marlene Dea, Allen Ebens, et al.
Pageof 67

Showing results (561-570 of 668) with videos related to

Sort By:
Pageof 67
Pediatric Blood & Cancer|September 25, 2012
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium studySusan M Blaney, Michael Tagen, Arzu Onar-Thomas, et al.
Advances in Health Sciences Education : Theory and Practice|September 1, 2011
Students' learning as the focus for shared involvement between universities and clinical practice: a didactic model for postgraduate degree projectsJ Öhlén, L Berg, E Björk Brämberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trialS M Blaney, N L Seibel, M O'Brien, et al.
Brain : a Journal of Neurology|December 20, 2021
Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brainYouJin Lee, Morgan R Miller, Marty A Fernandez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1993
Phase I study of high-dose piroxantrone with granulocyte colony-stimulating factorD M Savarese, A M Denicoff, S L Berg, et al.
Cancer|November 6, 2018
A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children's Oncology Group phase 1 and pilot consortium trial (ADVL1315)James I Geller, Elizabeth Fox, Brian K Turpin, et al.
Cell|September 17, 2004
Identification of a human heme exporter that is essential for erythropoiesisJohn G Quigley, Zhantao Yang, Mark T Worthington, et al.
The Gerontologist|October 4, 2005
Driving and dementia of the Alzheimer type: beliefs and cessation strategies among stakeholdersMargaret A Perkinson, Marla L Berg-Weger, David B Carr, et al.
Pediatric Blood & Cancer|January 8, 2024
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumorsKristy L Pilbeam, Kamnesh Pradhan, James Croop, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 23, 2004
An integrative biology approach for analysis of drug action in models of human vascular inflammationEric J Kunkel, Marlene Dea, Allen Ebens, et al.
Pageof 67